Meridian Bioscience calls $4 million of 7% convertibles

New York, Dec. 20 - Meridian Bioscience Inc. said it will redeem $4 million of its 7% convertible subordinated debentures due Sept. 1, 2006 on Jan. 14.

Up to the close of business on Jan. 13, holders can convert the securities into stock at a price of $16.09. Meridian stock closed at $18.45 on Monday.

Debentures not converted will be redeemed at par plus accrued interest.

Following the redemption, the Cincinnati-based life science company will have $7.7 million of the convertibles outstanding.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.